Drug intelligence / Profile preview

chlorpheniramine + phenylephrine

Development stage
Unknown
Lead developer
China Resources Sanjiu Medical & Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Chlorpheniramine + phenylephrine is an oral combination drug used to relieve symptoms associated with the common cold, seasonal allergies, hay fever, or sinus inflammation. It combines two active ingredients: **Chlorpheniramine**, an antihistamine that blocks histamine H1 receptors to reduce symptoms like sneezing, itching, watery eyes, and runny nose; **Phenylephrine**, a sympathomimetic decongestant that acts as an alpha‑adrenergic receptor agonist to constrict blood vessels in the nasal passages, thereby reducing nasal congestion. This combination provides short-term relief of multiple upper respiratory symptoms such as runny or stuffy nose, sneezing, itchy/watery eyes or throat, sinus congestion/pressure. It is available over-the-counter in various formulations including tablets and liquids[1][2][4][6].

Brand names
Actifed Cold and AllergyAllerest PEChlorTan DCold and Allergy ReliefEd A-HistMaxichlor PEHNoHistPhenagilSudafed PE Sinus and Allergy
Other names
chlorpheniramine and phenylephrinechlorpheniramine maleate + phenylephrine
02

Targets

ADRA1A (α1A)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on chlorpheniramine + phenylephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chlorpheniramine + phenylephrine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call